A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors
Clinical trial NCT02162719 · COMPLETED
Trial details
- NCT number
- NCT02162719
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-19
- Primary completion
- 2016-06-07
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.